Curevo Vaccine
Unicorn exit · $1.5BAcquiredBothell, US · Founded 2017 · 43 employees on LinkedIn · 9 known investors
Find your way into Curevo Vaccine
Sign up to see every warm intro you have to Curevo Vaccine
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Curevo Vaccine team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Acquired by Eli Lilly and Company May 2026 · $1.5B (up to $1.5 billion cash, including upfront and milestone payment) · source ↗
Curevo Vaccine is a biotech company developing next-generation non-mRNA vaccines, with a focus on infectious diseases. It operates in clinical-stage vaccine development.
Founders & leadership


Investors · 9
How we know: Adjuvant Capital's portfolio page · statnews.com · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: HBM Healthcare Investments's portfolio page · funding news · open dataset · 5k.vc investor directory · Not right? Tell us
How we know: Medicxi's portfolio page · board seat on SEC Form D · funding news · statnews.com · Not right? Tell us
How we know: OrbiMed's portfolio page · funding news · statnews.com · the VCSheet dataset · Not right? Tell us
How we know: RA Capital's portfolio page · funding news · statnews.com · Not right? Tell us
How we know: Sanofi Ventures's portfolio page · funding news · statnews.com · the VCSheet dataset · open dataset · 5k.vc investor directory · Not right? Tell us
Also in the syndicate · 2
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BMar 2025Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Curevo Vaccine do?
- Curevo Vaccine is a biotech company developing next-generation non-mRNA vaccines, with a focus on infectious diseases. It operates in clinical-stage vaccine development.
- Who are Curevo Vaccine's investors?
- Curevo Vaccine's investors include Adjuvant Capital, HBM Healthcare Investments, Medicxi, OrbiMed, RA Capital, Sanofi Ventures, Janus Henderson Investors.
- Where is Curevo Vaccine headquartered?
- Curevo Vaccine is headquartered in Bothell, US.




